Novo Gets FDA Approval For First-Of-Its-Kind Weekly Growth Hormone Treatment For Children With Turner Syndrome
The approval was supported by Novo’s Phase 3 Real8 trial involving 105 children with Turner syndrome.
The approval was supported by Novo’s Phase 3 Real8 trial involving 105 children with Turner syndrome.